Papillary thyroid carcinoma shows elevated levels of 2-hydroxyglutarate

@article{Rakheja2010PapillaryTC,
  title={Papillary thyroid carcinoma shows elevated levels of 2-hydroxyglutarate},
  author={Dinesh Rakheja and Richard L. Boriack and Midori Mitui and Shama Khan Khokhar and Shelby A. Holt and Payal Kapur},
  journal={Tumor Biology},
  year={2010},
  volume={32},
  pages={325-333}
}
Elevated levels of d-2-hydroxyglutarate (d-2-HG) occur in gliomas and myeloid leukemias associated with mutations of IDH1 and IDH2. l-2-Hydroxyglutaric aciduria, an inherited metabolic disorder, predisposes to brain tumors. Therefore, we asked whether sporadic cancers, without IDH1 or IDH2 hot-spot mutations, show elevated 2-hydroxyglutarate levels. We retrieved 15 pairs of frozen papillary thyroid carcinoma (PTC) and adjacent non-neoplastic thyroid, and 14 pairs of hyperplastic nodule (HN) and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 40 references

D-2-Hydroxyglutaric aciduria: Unravelling the biochemical pathway and the genetic defect

Journal of Inherited Metabolic Disease • 2006
View 8 Excerpts
Highly Influenced

l-2-Hydroxyglutaric aciduria, a disorder of metabolite repair

Journal of Inherited Metabolic Disease • 2008
View 6 Excerpts
Highly Influenced

not your typical oncogenes

ZJ Reitman, DW Parsons, Yan H. IDH1, IDH2
Cancer Cell. 2010;17:215–6. Tumor Biol. • 2011
View 1 Excerpt

Similar Papers

Loading similar papers…